Children with rare diseases
    deserve therapeutic answers

    Discover
    ORPHELIA Pharma

    Development of essential
    medicines in the field of rare
    pediatric diseases.
    Read more

    ORPHELIA Pharma’s mission

    Four key pillars :

    Latest news

    1 December 2025

    Orphalan, a global pharmaceutical company specializing in the development and commercialization of orphan drugs, announces the acquisition of Orphelia Pharma, a French pharmaceutical company dedicated to rare and serious pediatric diseases in neurology and oncology.

    Read More >
    12 March 2025

    Orphelia Pharma provides update on KIZFIZO® regulatory submission with the European Medicines Agency

    Read More >
    18 November 2024

    Orphelia Pharma provides update on the regulatory submission of KIZFIZO® with the European Medicines Agency

    Read More >